💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

European shares rise on firm pharmas; Actelion soars

Published 11/17/2010, 12:58 PM
Updated 11/17/2010, 01:00 PM
HG
-

* FTSEurofirst 300 ends 0.5 pct higher after Tuesday's fall

* Drugmaker shares among top gainers; Actelion jumps 9 pct

* Focus remains on debt situation in Ireland

By Atul Prakash

LONDON, Nov 17 (Reuters) - European equities bounced back on Wednesday, with a surge in Actelion on reports of bid interest from Amgen boosting pharmaceuticals, while miners rose after supply worries pushed up metals prices.

The FTSEurofirst 300 index of top European shares closed 0.5 percent higher at 1,092.46 points, rebounding after suffering a 2.3 percent drop on Tuesday -- the index's biggest one-day retreat in nearly five months.

Actelion jumped more than 9 percent on reports the world's largest biotech firm Amgen was studying a takeover offer for the Swiss drugmaker, which said it was in "regular dialogue" with other industry players.

GlaxoSmithKline rose 2.4 percent following backing from a U.S. advisory panel for its lupus drug Benlysta, seen as a potential blockbuster, while Roche and Sanofi-Aventis rose 1.3 percent and 1.7 percent respectively.

Investors kept a close eye on the situation in Ireland, which agreed to work with a European Union-IMF mission on urgent steps to shore up its shattered banking sector, a process that could lead to a bailout despite Dublin's deep reluctance.

"The picture remains that the euro zone is under severe tensions and that the underlying causes for the tensions will not be overcome any time soon. The equity markets remain vulnerable to temporary increases in this kind of tension," said Tammo Greetfeld, equity strategist at UniCredit.

"If Ireland gets the financial aid, then in the short term this should lead to some relief for the equity market. However, any form of financial assistance is not a solution as such to the underlying causes of the tensions in the euro zone."

MINERS ADVANCE

Miners featured among the top gainers, with the STOXX 600 European basic resources sector index rising 0.8 percent after slumping 5 percent on Tuesday, as copper rose 0.8 percent on supply concerns following a strike at the world's third-largest copper mine in Chile. Nickel prices were up 4.5 percent.

BHP Billiton, Anglo American, Antofagasta and Rio Tinto rose 0.3 to 0.8 percent.

The Euro STOXX 50 rose 0.8 percent to 2,802.70 points. Technically the index is likely to face stiff resistance at 2,805.95, the index's 61.8 percent Fibonacci retracement of a fall from an April high to a May low.

Alexandre Le Drogoff, technical analyst at Aurel BGC, said the euro zone's blue chip index could soon fall again.

"The index seems to be heading towards a test of the lower band of its upward channel. Weakness signals are increasing, with yesterday's Marubozu of Yin, and there has been a rise in volumes over the past few days, just like we saw during the corrections in January and April," he said.

Among individual movers, British credit information group Experian Plc rose 6.3 percent after raising its interim dividend and saying it continued to look at ways of returning cash to shareholders after a stronger than expected first half.

Across Europe, Britain's FTSE 100, Germany's DAX, France's CAC 40, Portugal's PSI 20, Ireland's ISEQ, Spain's IBEX 35 and Italy's MIB rose 0.4 to 1.5 percent. The Thomson Reuters Peripheral Eurozone Countries Index was up 0.9 percent.

"With all the discussions taking place between Dublin and Brussels, the only certainty at the moment is that the uncertainty will continue to limit the upside," said Michael Hewson, market analyst at CMC Markets. (Additional reporting by Blaise Robinson in Paris; Editing by Greg Mahlich)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.